NOVEL CLINICAL TRIALS TOOLBOX
The research community across CU Anschutz Medical Campus performs hundreds of clinical trials in a broad range of research fields – all crucial to answering difficult scientific and health questions, which can lead to the development of new and enhanced drugs and treatments.
The Novel Clinical Trials Program strives to provide the necessary expertise and resources to expand the research infrastructure to support new and innovative study designs. The program will primarily focus on Decentralized Clinical Trials (DCT).
What are DCTs?
A clinical trial where some or all of the trial activities occur at locations other than the traditional clinical trial sites.
Goals:
DCT Working Group
A leadership advisory group that helps the CU Anschutz Research Community that assesses resource, infrastructure, and personnel needs and assists with operationalizing decentralized study designs and approaches.
DCT Community of Practice
A platform for all members of the CU Anschutz Research Community to come together to share ideas, discuss challenges, and troubleshoot solutions for novel ideas and decentralized clinical trials.
Join our DCT Community of Practice
If you are part of the CU Anschutz research community and would like to join the DCT Community of Practice, please email Kiley B. Vander Wyst, PhD, MPH.
Our expertise is the development, implementation, and oversight of decentralized, virtual, hybrid, and pragmatic clinical trials; here's how it works:
NOVEL CLINICAL TRIALS TOOLBOX